Showing results (291-300 of 1,831) with videos related to

Sort By:
Pageof 184
ESMO Open|December 3, 2025
Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)L Dercle, S Geyer, A B Nixon, et al.
ESMO Open|November 28, 2025
Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)T Link, M Reinisch, M Just, et al.
ESMO Open|January 22, 2026
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1C Vaklavas, M Oliveira, A C Armstrong, et al.
ESMO Open|January 22, 2026
Phase II trial, multicenter, first-line paclitaxel-avelumab treatment of inoperable angiosarcoma (KCSG UN 18-15)H R Kim, M Kim, M J Kang, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
ESMO Open|November 21, 2025
Whole-exome ctDNA sequencing reveals intratumoral heterogeneity and drivers of relapse in locally advanced head and neck cancerG Bruixola, J Martín-Arana, F Gimeno-Valiente, et al.
ESMO Open|November 19, 2025
The risk of lung cancer from vaping or e-cigarette usage: a systematic reviewS Mohapatra, A Tiwari, A Kandala, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
ESMO Open|November 19, 2025
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence studyB A Maiorano, A Cigliola, V Tateo, et al.
ESMO Open|November 21, 2025
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumorsA Minchom, O Lindén, D G Knapen, et al.
Pageof 184